Literature DB >> 8685254

Proton dose monitoring with PET: quantitative studies in Lucite.

U Oelfke1, G K Lam, M S Atkins.   

Abstract

The feasibility of using PET for proton dose monitoring is examined here in detail. First experimental studies in a Lucite phantom have been performed at the medical TRIUMF proton beamline for proton energies of 62 MeV and 110 MeV. The proton dose delivered to the phantom ranged from 16 Gy up to 317 Gy. The induced activity was analysed 20-40 min after the irradiation with a PET scanner. The obtained depth activity profiles were compared to our calculation based on a model using available isotope production cross-section data. Both the observed absolute count rates and the activity profiles were found to agree very well with this model. Effects such as proton range straggling, inelastic nuclear interactions and the energy spectrum of the emitted positrons were studied in detail and found to change the activities by 5-10%. The lateral deposition of dose in the phantom could be very well localized by the induced activity. However, the spatial correlation between dose depth profiles and depth activity profiles was found to be poor, hence the extraction of isodose profiles from activity profiles seems to be very difficult.

Mesh:

Substances:

Year:  1996        PMID: 8685254     DOI: 10.1088/0031-9155/41/1/013

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  19 in total

1.  Nuclear collision processes around the Bragg peak in proton therapy.

Authors:  Yuka Matsuzaki; Hiroyuki Date; Kenneth Lee Sutherland; Yoshiaki Kiyanagi
Journal:  Radiol Phys Technol       Date:  2009-12-29

2.  Improved MAGIC gel for higher sensitivity and elemental tissue equivalent 3D dosimetry.

Authors:  Xuping Zhu; Timothy G Reese; Elizabeth M Crowley; Georges El Fakhri
Journal:  Med Phys       Date:  2010-01       Impact factor: 4.071

3.  Clinical CT-based calculations of dose and positron emitter distributions in proton therapy using the FLUKA Monte Carlo code.

Authors:  K Parodi; A Ferrari; F Sommerer; H Paganetti
Journal:  Phys Med Biol       Date:  2007-05-17       Impact factor: 3.609

Review 4.  Update on novel trends in PET/CT technology and its clinical applications.

Authors:  Stephan Walrand; Michel Hesse; François Jamar
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

Review 5.  Image guidance in proton therapy for lung cancer.

Authors:  Miao Zhang; Wei Zou; Boon-Keng Kevin Teo
Journal:  Transl Lung Cancer Res       Date:  2018-04

6.  Simulation of positron emitters for monitoring of dose distribution in proton therapy.

Authors:  Mohsen Mashayekhi; Ali Asghar Mowlavi; Sayyed Bijan Jia
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-31

7.  Proton therapy dosimetry using positron emission tomography.

Authors:  Matthew T Studenski; Ying Xiao
Journal:  World J Radiol       Date:  2010-04-28

8.  PET/CT imaging for treatment verification after proton therapy: a study with plastic phantoms and metallic implants.

Authors:  Katia Parodi; Harald Paganetti; Ethan Cascio; Jacob B Flanz; Ali A Bonab; Nathaniel M Alpert; Kevin Lohmann; Thomas Bortfeld
Journal:  Med Phys       Date:  2007-02       Impact factor: 4.071

9.  Feasibility of proton-activated implantable markers for proton range verification using PET.

Authors:  Jongmin Cho; Geoffrey Ibbott; Michael Gillin; Carlos Gonzalez-Lepera; Uwe Titt; Harald Paganetti; Matthew Kerr; Osama Mawlawi
Journal:  Phys Med Biol       Date:  2013-10-08       Impact factor: 3.609

10.  Determination of elemental tissue composition following proton treatment using positron emission tomography.

Authors:  Jongmin Cho; Geoffrey Ibbott; Michael Gillin; Carlos Gonzalez-Lepera; Chul Hee Min; Xuping Zhu; Georges El Fakhri; Harald Paganetti; Osama Mawlawi
Journal:  Phys Med Biol       Date:  2013-05-16       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.